March 1, 2009 Issam Saliba, MD and Jose N. Fayad, MD
article
From the Department of Otolaryngology-Head and Neck Surgery, Montreal University Hospital Center (Dr. Saliba), and the House Ear Clinic, Los Angeles (Dr. Fayad)
September 25, 2008 Todd A. Hillman, MD, Douglas A. Chen, MD, FACS, and Russell Fuhrer, MD
article
Abstract
A review of medical records of patients undergoing radiotherapy for facial nerve tumors was undertaken to determine subsequent facial nerve results, hearing results, and tumor control. Two patients with facial nerve tumors received this treatment. Facial nerve function remains excellent in one patient and significantly improved in the other. Neither tumor demonstrated growth. Current philosophies of facial nerve schwannoma management attempt to balance tumor control with facial nerve function. Radiotherapy for these tumors appears to preserve short-term facial function and may be a viable alternative to surgical management.
August 31, 2008 Amit Prasai, MRCS, Stephen E.M. Jones, FRCS (ORL-HNS), Justin Cross, MRCP, FRCR, and David A. Moffat, MA, FRCS
article
Abstract
Schwannoma of the facial nerve is an extremely rare condition with an incidence far lower than that of vestibular schwannoma. We discuss the case of a woman who had been diagnosed as having vestibular schwannoma and referred to our hospital. Initially, we concurred with the diagnosis, but on reassessment of magnetic resonance imaging scans before surgery, we revised the diagnosis to facial nerve schwannoma. This allowed us to counsel the patient appropriately preoperatively regarding the expected outcome. We discuss the importance of this case and the lessons to be learned from it.
July 31, 2008 Richard R. Gacek, MD
June 30, 2008 Enrique Palacios, MD, FACR, Jack Breaux, MD, and Jorge E. Alvernia, MD
March 31, 2008 John P. Leonetti, MD, Chad A. Zender, MD, Daryl Vandevender, MD, and Sam J. Marzo, MD
article
Abstract
We conducted a retrospective case review at our tertiary care academic medical center to assess the long-term results of microvascular free-tissue transfer to achieve facial reanimation in 3 patients. These patients had undergone wide-field parotidectomy with facial nerve resection. Upper facial reanimation was accomplished with a proximal facial nerve-sural nerve graft, and lower facial movement was achieved through proximal facial nerve-long thoracic (serratus muscle) nerve anastomosis. Outcomes were determined by grading postoperative facial nerve function according to the House-Brackmann system. All 3 patients were able to close their eyes independent of lower facial movement, and all 3 had achieved House-Brackmann grade III function. We conclude that reanimating the paralyzed face with microvascular free-tissue transfer provides anatomic coverage and mimetic function after wide-field parotidectomy. Synkinesis is reduced by separating upper- and lower-division reanimation.
February 1, 2007 Henriëtte E. Westerlaan, MD; Joost Gravendeel, MD
February 1, 2007 Sofia Avitia, MD; Jason S. Hamilton, MD; Ryan F. Osborne, MD, FACS
January 1, 2007 Joni K. Doherty, MD, PhD; Mona Yong, MD; Dennis Maceri, MD
July 31, 2006 Natalie P. Steele, MD; Andrea Vambutas, MD
May 31, 2006 Sejal P. Sarolia, BS; Christopher J. Danner, MD; Eren Erdem, MD
December 1, 2005 Peter A. Weisskopf, MD; Derald E. Brackmann, MD
